At Walden Biosciences, we are relentlessly focused on developing first-in-class, highly-targeted therapies for individuals living with kidney disease. Our accomplished team members are expert drug hunters and we have strong financial backing from blue chip investors (e.g., ARCH Venture Partners, UCB Ventures).
Our culture is collaborative and entrepreneurial, and our team is dynamic and driven by data and innovation. We want to make the best decisions with the best available information, lead by example and bring transformative medicines to patients in need.
Walden Biosciences is based in the heart of Cambridge, MA between Harvard, Massachusetts Institute of Technology (MIT), and Massachusetts General Hospital.
Join us for a professional experience like no other, as we seek to bring patients the first therapies targeted to the kidney.